Effect of Sweet almond on ADHD

Phase 2

• Conditions: Attention-Deficit/Hyperactivity Disorder.; Disturbance of activity and attention

• Registration Number: IRCT2015050922165N1
• Lead Sponsor: Vice Chancellor for research of Tehran university School of Traditional Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Age 6 to 14 years; Combined subtype ADHD diagnosis by a psychiatrist; Obtain written informed consent from each patient's parent or guardian; No mental retardation (I.Q.>70); Non use of other Complementary and Alternative Medicine methods; No any significant chronic medical condition including cardiovascular disease, GI disorders, seizures; No other psychiatric disorder such as schizophrenia; No organic brain disorder; No clear developmental disorders and Malnutrition; no recent treatment with psychotherapic drugs; Not clinically current abuse or dependence on drugs within 6 months; New diagnoses of disorder and No other drug use; Not required behavior Therapy; No sensitivity to sweet almond and its products; Non-concurrent use of other products containing almonds (Nuts, nougat)
Exclusion criteria: Symptoms of sensitivity to sweet almond; Intolerance sweet almond syrup; Complications increase in moisture in the body; Dissatisfaction of parents or patient; The risk of other mental illness that requires treatment during the study

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ADHD severity. Timepoint: weeks 2, 4, 6 and 8 after starting the drug. Method of measurement: Standard Teacher and Parent ADHD rating scale.

Secondary Outcome Measures

Name	Time	Method
Adverse effect of sweet almond syrup (skin & respiratory sensitivity ...). Timepoint: weeks 2, 4, 6 and 8 after starting the drug. Method of measurement: Questionnaire.;Adverse effect of Ritalin (headache, abdominal pain, nausea, ...). Timepoint: weeks 2, 4, 6 and 8 after starting the drug. Method of measurement: Questionnaire.